The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGuild Esports . Share News (GILD)

Share Price Information for Guild Esports . (GILD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.225
Bid: 0.20
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.05 (25.00%)
Open: 0.225
High: 0.225
Low: 0.225
Prev. Close: 0.225
GILD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Guild Esports teams with PlayStation for FIFA22 tournament

Mon, 13th Dec 2021 22:01

Guild Esports PLC - London-based esports company - Says that it has partnered with Sony's PlayStation to create a FIFA22 tournament, 'The Guild Academy Challenge'. The event starts on Monday and runs to Wednesday and is open for participation to all PlayStation 4 FIFA22 players across Europe through the PlayStation online gaming network.

Chief Executive Officer Kal Hourd says: "The FIFA franchise is a key part of our growth strategy and this tournament complements the investment we have made in our FIFA esports team, enabling Guild to leverage the game's vast and growing worldwide fanbase."

Current stock price: 3.40 pence

Year-to-date change: down 36%

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
21 Oct 2020 20:26

IN BRIEF: Guild Esports Signs Team To Compete In Valorant Game

IN BRIEF: Guild Esports Signs Team To Compete In Valorant Game

Read more
19 Oct 2020 11:54

Guild Esports Inks GBP3.6 Million Sponsorship Deal With Fintech Firm

Guild Esports Inks GBP3.6 Million Sponsorship Deal With Fintech Firm

Read more
21 Mar 2018 07:00

FOCUS-GlaxoSmithKline prescribes commercial reboot for pharma division

* GSK reallocating budget to key new drugs, top 10 markets * Pharma head says commercial revamp matches R&D changes * Cancer a big pipeline focus, promise lies from Ben March 21

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.